Direxion Daily S&P Biotech Bear 3X ETF
LABD
LABD
17 hedge funds and large institutions have $26.5M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.32% less ownership
Funds ownership: 4.16% → 3.84% (-0.32%)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
Holders
17
Holding in Top 10
–
Calls
$20M
Puts
$8.79M
Top Buyers
| 1 | +$4.64M | |
| 2 | +$1.63M | |
| 3 | +$1.2M | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$374K |
| 5 |
Jane Street
New York
|
+$272K |
Top Sellers
| 1 | -$2.18M | |
| 2 | -$1.46M | |
| 3 | -$453K | |
| 4 |
Goldman Sachs
New York
|
-$288K |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$266K |